Biodefense Research: the total market could reach as high as $50 billion within the next few years

(PRWEB) August 6, 2004 -- Research and Markets announces the addition of this new report entitled "Market Opportunities in Biodefense Research" to itss offerings.

Biodefense research represents one of the fastest growing markets for life science suppliers. Billions of dollars are being invested to support basic research on potential agents of bioterrorism as well as the development of vaccines, diagnostic tests and therapies to detect and counter the effects of a bioterrorist attack. In fact, when the budget allocated to the Department of Health and Human Services as well as the expenditures of other agencies, private institutions and corporations related to biodefense are considered, the total market could reach as high as $50 billion within the next few years. Despite this investment, relatively few tools and techniques are specifically designed for biodefense research, often leaving researchers to adapt products and methodologies currently designed for other uses.

Looking at the entire market potential, Market Opportunities in Biodefense Research not only reflects the experiences and opinions of over 265 scientists who are currently engaged in biodefense research, but also over 235 scientists who plan to conduct biodefense research within the next year. It provides a thorough analysis of the commercial opportunities in this market, including the rate at which new researchers are entering the field and barriers to adoption as well as the most commonly studied diseases and/or bioterrorism agents, approaches and techniques used and sources of funding. Respondents also disclosed unmet needs and identified areas where companies can focus their efforts to capture market share. With the appropriate research tools, scientists will be able to develop the tools for diagnosis, treatment, and prevention that will improve the response to future bioterrorist attacks as well as help deter the ravages of infectious disease outbreaks.

The major objectives of this report are as follows:
- Understand the overall objectives and specific targets of biodefense research in the U.S.
- Identify predominant tools and techniques employed in biodefense research to support market segmentation analysis
- Measure the rate of growth of biodefense research as a defined market within the life science industry
- Describe current obstacles encountered by scientists and technological developments required to advance biodefense research
- Highlight opportunities for life science suppliers to establish themselves as credible suppliers of research products to the biodefense market

For a complete index of this report click on http://www.researchandmarkets.com/reports/220694

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com